A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a study published online this week in the Journal of Antimicrobial Chemotherapy. In laboratory tests of rectal tis…
The May 16 edition of the Global Health themed issue of JAMA reveals a larger drop in all-cause adult mortality in those African countries with more intense operation of the AIDS relief program PEPFAR. The article’s background information states: “The …
On Thursday, a panel of outside experts that advises the US Food and Drug Administration (FDA) voted to support approval of the daily pill Truvada to prevent HIV in healthy people. The FDA is not obliged to follow the advice of its Antiviral Drugs A…
African-Americans with HIV are much less likely to adhere to drug therapy than others with the disease, according to a University of Michigan study. Moreover, untreated depression may greatly hinder adherence to antiretroviral therapy (ART) for all low…
Infants born to women who used the anti-HIV drug tenofovir as part of an anti-HIV drug regimen during pregnancy do not weigh less at birth and are not of shorter length than infants born to women who used anti-HIV drug regimens that do not include teno…
In this week’s PLoS Medicine, Luis Montaner from the Wistar Institute, Philadelphia, USA and colleagues retrospectively apply a potential capacity-saving CD4 count model to a cohort of HIV-infected patients on antiretroviral therapy. The study’s findi…
Expanding on previous research providing proof-of-principal that human stem cells can be genetically engineered into HIV-fighting cells, a team of UCLA researchers have now demonstrated that these cells can actually attack HIV-infected cells in a livin…
Researchers have gained important clues about immune system responses that could play a role in protecting people from HIV infection in follow-up studies from the world’s largest HIV vaccine trial to date. Results from laboratory studies based on the t…
Some of the key factors that fuel the HIV/AIDS epidemic amongst American women are physical violence, sexual abuse and other childhood and adult traumas. The fact that traumatized women have a higher infection risk has long been known amongst the scien…
A new analysis of research evidence suggests that one of the AIDS drug regimens increasingly used in developing countries and recommended by the World Health Organization (WHO), may have an unacceptably high risk of failure and rate of drug resistanc…
